These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10428424)

  • 21. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors.
    Hervás I; Artigas F
    Eur J Pharmacol; 1998 Sep; 358(1):9-18. PubMed ID: 9809863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hippocampal Bcl-2 expression is selectively increased following chronic but not acute treatment with antidepressants, 5-HT(1A) or 5-HT(2C/2B) receptor antagonists.
    Murray F; Hutson PH
    Eur J Pharmacol; 2007 Aug; 569(1-2):41-7. PubMed ID: 17582397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat.
    Ferraro L; Fuxe K; Agnati L; Tanganelli S; Tomasini MC; Antonelli T
    Synapse; 2005 Mar; 55(4):230-41. PubMed ID: 15668907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI).
    Hjorth S; Auerbach SB
    Behav Brain Res; 1996; 73(1-2):281-3. PubMed ID: 8788519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant-anticonvulsant action.
    Smolders I; Clinckers R; Meurs A; De Bundel D; Portelli J; Ebinger G; Michotte Y
    Neuropharmacology; 2008 May; 54(6):1017-28. PubMed ID: 18378264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
    Dawson LA; Nguyen HQ
    Neuropharmacology; 2000 Apr; 39(6):1044-52. PubMed ID: 10727715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of LPM570065, a novel triple reuptake inhibitor, on extracellular serotonin, dopamine and norepinephrine levels in rats.
    Zhang R; Li X; Shi Y; Shao Y; Sun K; Wang A; Sun F; Liu W; Wang D; Jin J; Li Y
    PLoS One; 2014; 9(3):e91775. PubMed ID: 24614602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional regulation by dopamine receptors of serotonin release from the rat hippocampus: in vivo microdialysis study.
    Matsumoto M; Yoshioka M; Togashi H; Ikeda T; Saito H
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):621-9. PubMed ID: 8738295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic neurochemical and behavioral effects of fluoxetine and 5-HT1A receptor antagonists.
    Trillat AC; Malagié I; Mathe-Allainmat M; Anmella MC; Jacquot C; Langlois M; Gardier AM
    Eur J Pharmacol; 1998 Sep; 357(2-3):179-84. PubMed ID: 9797034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation.
    Rutter JJ; Gundlah C; Auerbach SB
    Synapse; 1995 Jul; 20(3):225-33. PubMed ID: 7570354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test.
    Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
    Eur J Pharmacol; 2004 Mar; 487(1-3):133-42. PubMed ID: 15033385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.
    Gobbi M; Moia M; Pirona L; Ceglia I; Reyes-Parada M; Scorza C; Mennini T
    J Neurochem; 2002 Sep; 82(6):1435-43. PubMed ID: 12354291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
    Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN; Greenslade RG; Cooper J
    Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of quinine on autoreceptor-regulated serotonin release in the rat hippocampus.
    Li MY; Reith ME
    Eur J Pharmacol; 1997 Dec; 340(2-3):145-51. PubMed ID: 9537808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-hydroxytryptamine- and dopamine-releasing effects of ring-substituted amphetamines on rat brain: a comparative study using in vivo microdialysis.
    Matsumoto T; Maeno Y; Kato H; Seko-Nakamura Y; Monma-Ohtaki J; Ishiba A; Nagao M; Aoki Y
    Eur Neuropsychopharmacol; 2014 Aug; 24(8):1362-70. PubMed ID: 24862256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J; De Montigny C; Blier P
    Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor.
    Gundlah C; Martin KF; Heal DJ; Auerbach SB
    J Pharmacol Exp Ther; 1997 Nov; 283(2):581-91. PubMed ID: 9353373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action.
    Lucas G; Rymar VV; Du J; Mnie-Filali O; Bisgaard C; Manta S; Lambas-Senas L; Wiborg O; Haddjeri N; Piñeyro G; Sadikot AF; Debonnel G
    Neuron; 2007 Sep; 55(5):712-25. PubMed ID: 17785179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.